Chittasupho, C.; Umsumarng, S.; Srisawad, K.; Arjsri, P.; Phongpradist, R.; Samee, W.; Tingya, W.; Ampasavate, C.; Dejkriengkraikul, P.
Inhibition of SARS-CoV-2-Induced NLRP3 Inflammasome-Mediated Lung Cell Inflammation by Triphala-Loaded Nanoparticle Targeting Spike Glycoprotein S1. Pharmaceutics 2024, 16, 751.
https://doi.org/10.3390/pharmaceutics16060751
AMA Style
Chittasupho C, Umsumarng S, Srisawad K, Arjsri P, Phongpradist R, Samee W, Tingya W, Ampasavate C, Dejkriengkraikul P.
Inhibition of SARS-CoV-2-Induced NLRP3 Inflammasome-Mediated Lung Cell Inflammation by Triphala-Loaded Nanoparticle Targeting Spike Glycoprotein S1. Pharmaceutics. 2024; 16(6):751.
https://doi.org/10.3390/pharmaceutics16060751
Chicago/Turabian Style
Chittasupho, Chuda, Sonthaya Umsumarng, Kamonwan Srisawad, Punnida Arjsri, Rungsinee Phongpradist, Weerasak Samee, Wipawan Tingya, Chadarat Ampasavate, and Pornngarm Dejkriengkraikul.
2024. "Inhibition of SARS-CoV-2-Induced NLRP3 Inflammasome-Mediated Lung Cell Inflammation by Triphala-Loaded Nanoparticle Targeting Spike Glycoprotein S1" Pharmaceutics 16, no. 6: 751.
https://doi.org/10.3390/pharmaceutics16060751
APA Style
Chittasupho, C., Umsumarng, S., Srisawad, K., Arjsri, P., Phongpradist, R., Samee, W., Tingya, W., Ampasavate, C., & Dejkriengkraikul, P.
(2024). Inhibition of SARS-CoV-2-Induced NLRP3 Inflammasome-Mediated Lung Cell Inflammation by Triphala-Loaded Nanoparticle Targeting Spike Glycoprotein S1. Pharmaceutics, 16(6), 751.
https://doi.org/10.3390/pharmaceutics16060751
